marbofloxacin has been researched along with Leishmaniasis, Visceral in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Badino, P; Farca, AM; Ferroglio, E; Miniscalco, B; Monticelli, P; Odore, R; Trisciuoglio, A | 1 |
Dereure, J; Keck, N; Lami, P; Libert, C; Pratlong, F; Ravel, C | 1 |
Dugas, B; Mazier, D; Pino, P; Rougier, S; Vouldoukis, I; Woehrlé, F | 1 |
Fournel, S; Pérès, S; Rougier, S; Vouldoukis, I; Woehrlé, F | 1 |
1 trial(s) available for marbofloxacin and Leishmaniasis, Visceral
Article | Year |
---|---|
Efficacy of different treatment regimens of marbofloxacin in canine visceral leishmaniosis: a pilot study.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Enzyme Inhibitors; Female; Fluoroquinolones; Follow-Up Studies; Leishmaniasis, Visceral; Male; Pilot Projects; Recurrence; Time Factors; Treatment Outcome | 2008 |
3 other study(ies) available for marbofloxacin and Leishmaniasis, Visceral
Article | Year |
---|---|
Canine leishmaniosis: in vitro efficacy of miltefosine and marbofloxacin alone or in combination with allopurinol against clinical strains of Leishmania infantum.
Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Synergism; Fluoroquinolones; Leishmania infantum; Leishmaniasis, Visceral; Phosphorylcholine | 2012 |
Leishmania infantum infection in two captive barbary lions (Panthera leo leo).
Topics: Allopurinol; Animals; Animals, Zoo; Antiprotozoal Agents; Drug Therapy, Combination; Female; Fluoroquinolones; Leishmania infantum; Leishmaniasis, Visceral; Lions | 2012 |
Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Fluoroquinolones; Interleukin-6; Leishmania infantum; Leishmaniasis, Visceral; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Nitric Oxide; Organometallic Compounds; Parasitic Sensitivity Tests; Quinolones; Tumor Necrosis Factor-alpha | 2006 |